NL-OMON24920
Recruiting
未知
A multicentre, assessor-blinded, randomized controlled trial to investigate the effectiveness of a blended intervention, focused on personal feedback and coaching regarding physical activity and protein intake, after discharge in patients who have undergone elective gastro-intestinal or lung cancer surgery
Amsterdam Movement Sciences, Cancer Center Amsterdam0 sites161 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Amsterdam Movement Sciences, Cancer Center Amsterdam
- Enrollment
- 161
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\- Gepland voor oncologische GI of longchirurgie |
Exclusion Criteria
- •\- Wigexcisie long |
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
A multicentre, assessor-blinded, randomized controlled trial to investigate the effectiveness of a blended intervention, focused on personal feedback and coaching regarding physical activity and protein intake, after discharge in patients who have undergone elective gastro-intestinal or lung cancer surgeryNL-OMON51948Vrije Universiteit Medisch Centrum161
Active, not recruiting
Not Applicable
A randomized, assessor-blinded, multicenter, international study investigating efficacy, patient's acceptance, safety and tolerability of Sodium Phosphate tablets compared to split dose Polyethylene Glycol for colon cleansing prior to colonoscopy.EUCTR2012-005115-13-ESABORATOIRES MAYOLY SPINDLER448
Completed
Phase 3
A Phase III clinical trial of Teriparatide in postmenopausal women with osteoporosisCTRI/2021/04/032769Intas Pharmaceuticals Ltd
Recruiting
Not Applicable
A superiority, confirmatory clinical trial to assess the efficacy of cognitive therapy software ‘NDTx-01’ in patients with autism spectrum disorder (ASD) or social communication disorders (SCD)Mental and behavioural disordersKCT0009699eudive Inc.80
Unknown
Phase 3
A clinical trial to study the safety and efficacy of a new drug biotinylated idraparinux (SSR126517E) as compared to another drug warfarin in the prevention of stroke and systemic thromboembolic events in patients with atrial fibrillatioHealth Condition 1: null- Atrial fibrillationHealth Condition 2: I489- Unspecified atrial fibrillation and atrial flutterCTRI/2008/091/000018SanofiSynthelabo India Limited9,600